Inventor
LINSLEY PETER
US17 patents
⚠️ This page may combine multiple inventors who share the name “LINSLEY PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ONCOGEN
7 patentsUS4906562AMar 6, 1990
Monocolonal antibodies and antigen for human non-small cell lung carcinomas
ONCOGEN61 citations96
US5091177AFeb 25, 1992
Monoclonal antibodies for treatment of human non-small cell lung carcinomas
ONCOGEN59 citations95
US4935495AJun 19, 1990
Monoclonal antibodies to the L6 glycolipid antigenic determinant found on human non-small cell lung carcinomas
ONCOGEN45 citations95
US5338678AAug 16, 1994
Expression of DNA sequences encoding a thermally stable cytosine deaminase from saccharomyces
ONCOGEN50 citations94
US4737579AApr 12, 1988
Monoclonal antibodies for human non-small cell lung carinomas
ONCOGEN35 citations91
US5545548AAug 13, 1996
Thermally stable cytosine deaminase from saccharomyces
ONCOGEN29 citations90
US4873188AOct 10, 1989
Method, monoclonal antibody, and monoclonal antibody fragments for detecting human non-small cell lung carcinomas and cell line for producing such antibodies
ONCOGEN5 citations61
SAREPTA THERAPEUTICS INC
4 patentsUS10066228B2Sep 4, 2018
Oligonucleotides for treating expanded repeat diseases
SAREPTA THERAPEUTICS INC6 citations82
US9944926B2Apr 17, 2018
Induced exon inclusion in spinal muscle atrophy
SAREPTA THERAPEUTICS INC10 citations81
US11674139B2Jun 13, 2023
Oligonucleotides for treating expanded repeat diseases
SAREPTA THERAPEUTICS INC1 citations60
US10577605B2Mar 3, 2020
Induced exon inclusion in spinal muscle atrophy
SAREPTA THERAPEUTICS INC0 citations49